China Pharma Holdings (CPHI) Reports Q2 Loss of $0.06
Tweet
Share
E-mailGet Alerts CPHI Hot Sheet
Join SI Premium – FREE
China Pharma Holdings (NYSE: CPHI) reported Q2 EPS of ($0.06), versus $0.03 reported last year. Revenue for the quarter came in at $3.5 million, versus $5.7 million reported last year.
For earnings history and earnings-related data on China Pharma Holdings (CPHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
- Southland Holdings (SLND) Misses Q2 EPS by 122c
- Mannatech (MTEX) Tops Q2 EPS by 53c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
